Cooper Companies Inc
Moat Score — Cooper Companies Inc
Total Moat Score
15 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 3 / 5 | Cooper benefits from FDA regulatory approval barriers on contact lenses and IUDs (Paragard is the only FDA-approved non-hormonal IUD) plus specialty patents in myopia-management and toric/multifocal lenses, though it lacks the singular consumer brand power of Acuvue or Alcon. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 2 / 5 | Manufacturing scale in a consolidated, oligopolistic contact lens industry provides some cost efficiency, but Cooper is not clearly the lowest-cost producer among the big four lens makers and faces daily-disposable commoditization pressure. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 3 / 5 | Specialty lens categories (toric, multifocal, myopia management) carry structurally higher margins and pricing than standard spherical lenses, and Paragard enjoys durable pricing given its unique regulatory position, though standard lenses face real price competition. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | Medical device and consumables sales exhibit no network effect between users. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 4 / 5 | Patients are individually fit and prescribed a specific lens by their eye doctor, and both patients and practitioners tend to stay put once established, creating meaningful recurring, subscription-like switching friction reinforced by fixed replacement schedules. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 3 / 5 | The contact lens market is a consolidated oligopoly of four major players (J&J, Alcon, Cooper, Bausch + Lomb) that collectively control most volume, a structure that discourages new entrants given the manufacturing scale and regulatory investment required, though the fertility/women's health side is more fragmented and competitive. |